Gene,Gene Symbol,Description,Biological Process (GO),Kinase Class (UniProt),Protein Function (Protein Atlas),Subcellular Location (Protein Atlas),Canonical Pathways,Hallmark Gene Sets
10803,CCR9,C-C motif chemokine receptor 9,"GO:0002304 gamma-delta intraepithelial T cell differentiation;GO:0002305 CD8-positive, gamma-delta intraepithelial T cell differentiation;GO:0042492 gamma-delta T cell differentiation",,Predicted intracellular proteins; CD markers; G-protein coupled receptors:Chemokines and chemotactic factors receptors; G-protein coupled receptors:GPCRs excl olfactory receptors,Plasma membrane (Approved); Additional: Endoplasmic reticulum,,
5354,PLP1,proteolipid protein 1,GO:0098990 AMPA selective glutamate receptor signaling pathway;GO:0035235 ionotropic glutamate receptor signaling pathway;GO:0022010 central nervous system myelination,,Human disease related genes:Nervous system diseases:Other nervous and sensory system diseases; Potential drug targets; Cancer-related genes:Candidate cancer biomarkers; Transporters; Human disease related genes:Congenital disorders of metabolism:Congenital disorders of lipid/glycolipid metabolism; Disease related genes,,,
6613,SUMO2,small ubiquitin like modifier 2,GO:0016925 protein sumoylation;GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process;GO:2000060 positive regulation of ubiquitin-dependent protein catabolic process,,Predicted intracellular proteins,Nuclear bodies;Nucleoplasm (Approved),(M115)PID REG GR PATHWAY,
3769,KCNJ13,potassium inwardly rectifying channel subfamily J member 13,GO:1990573 potassium ion import across plasma membrane;GO:0098659 inorganic cation import across plasma membrane;GO:0099587 inorganic ion import across plasma membrane,,Disease related genes; Transporters:Transporter channels and pores; Voltage-gated ion channels:Inwardly Rectifying Potassium Channels; Human disease related genes:Nervous system diseases:Eye disease; Potential drug targets,Nuclear membrane (Approved),,
29119,CTNNA3,catenin alpha 3,GO:0086073 bundle of His cell-Purkinje myocyte adhesion involved in cell communication;GO:0086042 cardiac muscle cell-cardiac muscle cell adhesion;GO:0098911 regulation of ventricular cardiac muscle cell action potential,,Predicted intracellular proteins; Human disease related genes:Cardiovascular diseases:Cardiac diseases; Disease related genes,,,
79184,BRCC3,BRCA1/BRCA2-containing complex subunit 3,GO:1900227 positive regulation of NLRP3 inflammasome complex assembly;GO:0141087 positive regulation of inflammasome-mediated signaling pathway;GO:2000001 regulation of DNA damage checkpoint,,Enzymes; Disease related genes; Predicted intracellular proteins; Peptidases:Metallopeptidases; Potential drug targets,Nucleoplasm (Supported),,
55840,EAF2,ELL associated factor 2,GO:0060770 negative regulation of epithelial cell proliferation involved in prostate gland development;GO:0060767 epithelial cell proliferation involved in prostate gland development;GO:0060768 regulation of epithelial cell proliferation involved in prostate gland development,,Predicted intracellular proteins,,,
443,ASPA,aspartoacylase,GO:0006083 acetate metabolic process;GO:0006531 aspartate metabolic process;GO:0022010 central nervous system myelination,,Enzymes; Human disease related genes:Congenital disorders of metabolism:Congenital disorders of amino acid metabolism; Potential drug targets; Predicted intracellular proteins; ENZYME proteins:Hydrolases; Human disease related genes:Nervous system diseases:Neurodegenerative diseases; Disease related genes,Cytosol (Supported),,
55450,CAMK2N1,calcium/calmodulin dependent protein kinase II inhibitor 1,GO:0007616 long-term memory;GO:0007613 memory;GO:0050729 positive regulation of inflammatory response,,Predicted intracellular proteins,Cell Junctions;Nuclear membrane (Approved); Additional: Centriolar satellite,,
220988,HNRNPA3,heterogeneous nuclear ribonucleoprotein A3,"GO:0000377 RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;GO:0000398 mRNA splicing, via spliceosome;GO:0000375 RNA splicing, via transesterification reactions",,Predicted intracellular proteins,Nucleoplasm (Approved),,(M5926)HALLMARK MYC TARGETS V1
3357,HTR2B,5-hydroxytryptamine receptor 2B,GO:0007208 phospholipase C-activating serotonin receptor signaling pathway;GO:0010513 positive regulation of phosphatidylinositol biosynthetic process;GO:0010511 regulation of phosphatidylinositol biosynthetic process,,G-protein coupled receptors:Serotonin receptors; Transporters; FDA approved drug targets:Small molecule drugs; G-protein coupled receptors:GPCRs excl olfactory receptors,Nucleoplasm (Supported),,
8528,DDO,D-aspartate oxidase,GO:0019478 D-amino acid catabolic process;GO:0006533 aspartate catabolic process;GO:0046416 D-amino acid metabolic process,,Enzymes; Predicted intracellular proteins; ENZYME proteins:Oxidoreductases,Cytosol (Enhanced),,
60592,SCOC,short coiled-coil protein,GO:0061635 regulation of protein complex stability;GO:0016239 positive regulation of macroautophagy;GO:0010508 positive regulation of autophagy,,Predicted intracellular proteins,Golgi apparatus;Nucleoplasm (Approved),,
7534,YWHAZ,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,GO:0090168 Golgi reassembly;GO:0051683 establishment of Golgi localization;GO:0048308 organelle inheritance,,Predicted intracellular proteins; Transporters:Accessory Factors Involved in Transport,,(M199)PID P38 MK2 PATHWAY; (M182)PID IL3 PATHWAY; (M247)PID INSULIN GLUCOSE PATHWAY,(M5922)HALLMARK UNFOLDED PROTEIN RESPONSE
7529,YWHAB,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta,GO:0051220 cytoplasmic sequestering of protein;GO:0035308 negative regulation of protein dephosphorylation;GO:0035305 negative regulation of dephosphorylation,,Cancer-related genes:Candidate cancer biomarkers; Predicted intracellular proteins,Cytosol (Supported),(M199)PID P38 MK2 PATHWAY; (M247)PID INSULIN GLUCOSE PATHWAY; (M30)PID HDAC CLASSII PATHWAY,(M5923)HALLMARK PI3K AKT MTOR SIGNALING
196294,IMMP1L,inner mitochondrial membrane peptidase subunit 1,GO:0006627 protein processing involved in protein targeting to mitochondrion;GO:0034982 mitochondrial protein processing;GO:0006465 signal peptide processing,,Enzymes; Predicted intracellular proteins; Peptidases:Serine-type peptidases,Mitochondria (Enhanced),,
84707,BEX2,brain expressed X-linked 2,GO:0031397 negative regulation of protein ubiquitination;GO:1903321 negative regulation of protein modification by small protein conjugation or removal;GO:1901874 negative regulation of post-translational protein modification,,Predicted intracellular proteins,Cytosol (Uncertain),,
6019,RLN2,relaxin 2,GO:0007565 female pregnancy;GO:0045766 positive regulation of angiogenesis;GO:0044703 multi-organism reproductive process,,Predicted secreted proteins; Predicted intracellular proteins,,,
5000,ORC4,origin recognition complex subunit 4,GO:0040038 polar body extrusion after meiotic divisions;GO:0033206 meiotic cytokinesis;GO:0006270 DNA replication initiation,,Human disease related genes:Congenital malformations:Other congenital malformations; Predicted intracellular proteins; Disease related genes,Nucleoli;Nucleoplasm (Supported),,
57142,RTN4,reticulon 4,GO:1905578 regulation of ERBB3 signaling pathway;GO:1905580 positive regulation of ERBB3 signaling pathway;GO:1905552 positive regulation of protein localization to endoplasmic reticulum,,Predicted intracellular proteins,Endoplasmic reticulum (Enhanced),(M153)PID P75 NTR PATHWAY,
124512,METTL23,"methyltransferase 23, arginine",GO:0044727 epigenetic programing of male pronucleus;GO:0044725 epigenetic programming in the zygotic pronuclei;GO:0043045 post-fertilization epigenetic regulation of gene expression,,Enzymes; Disease related genes; ENZYME proteins:Transferases; Predicted intracellular proteins; Human disease related genes:Other diseases:Mental and behavioural disorders; Potential drug targets,Vesicles (Approved),,
26292,MYCBP,MYC binding protein,GO:0007283 spermatogenesis;GO:0048232 male gamete generation;GO:0007276 gamete generation,,Predicted intracellular proteins,Nucleoplasm (Approved); Additional: Mitochondria,(M17)PID NOTCH PATHWAY,
10758,TRAF3IP2,TRAF3 interacting protein 2,GO:0002334 transitional two stage B cell differentiation;GO:0110012 protein localization to P-body;GO:0002332 transitional stage B cell differentiation,,Enzymes; Disease related genes; Potential drug targets; Human disease related genes:Immune system diseases:Other immune system diseases; ENZYME proteins:Transferases; Predicted intracellular proteins; Human disease related genes:Skin diseases:Skin and soft tissue diseases,Golgi apparatus (Approved); Additional: Vesicles,,
55064,SPATA6L,spermatogenesis associated 6 like,GO:0007283 spermatogenesis;GO:0048232 male gamete generation;GO:0007276 gamete generation,,Predicted intracellular proteins,,,
1687,GSDME,gasdermin E,GO:0002836 positive regulation of response to tumor cell;GO:0002839 positive regulation of immune response to tumor cell;GO:0002837 regulation of immune response to tumor cell,,Disease related genes; Transporters:Transporter channels and pores; Predicted intracellular proteins; Human disease related genes:Nervous system diseases:Ear disease; Potential drug targets,Cytosol (Supported),,(M5898)HALLMARK DNA REPAIR
11164,NUDT5,nudix hydrolase 5,GO:0019303 D-ribose catabolic process;GO:0006014 D-ribose metabolic process;GO:0019323 pentose catabolic process,,Enzymes; ENZYME proteins:Hydrolases; Predicted intracellular proteins; ENZYME proteins:Transferases,Vesicles (Approved); Additional: Centrosome;Nucleoplasm,,
27306,HPGDS,hematopoietic prostaglandin D synthase,GO:1905937 negative regulation of germ cell proliferation;GO:2000255 negative regulation of male germ cell proliferation;GO:2000254 regulation of male germ cell proliferation,,ENZYME proteins:Isomerase; Enzymes; ENZYME proteins:Transferases; Predicted intracellular proteins,Cytosol;Vesicles (Approved); Additional: Nucleoplasm,,
493860,CCDC73,coiled-coil domain containing 73,,,Predicted intracellular proteins,,,
10388,SYCP2,synaptonemal complex protein 2,GO:0000080 mitotic G1 phase;GO:0022403 cell cycle phase;GO:0044848 biological phase,,Human disease related genes:Reproductive system diseases:Reproductive system diseases; Predicted intracellular proteins; Disease related genes,Nucleoplasm (Approved),,
27329,ANGPTL3,angiopoietin like 3,GO:0010519 negative regulation of phospholipase activity;GO:0051005 negative regulation of lipoprotein lipase activity;GO:0051004 regulation of lipoprotein lipase activity,,Predicted secreted proteins; FDA approved drug targets:Biotech drugs; Human disease related genes:Congenital disorders of metabolism:Other congenital disorders of metabolism; Disease related genes,,(M160)PID AVB3 INTEGRIN PATHWAY; (M5883)NABA SECRETED FACTORS; (M5885)NABA MATRISOME ASSOCIATED,(M5934)HALLMARK XENOBIOTIC METABOLISM
2263,FGFR2,fibroblast growth factor receptor 2,GO:0035602 fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell;GO:0035603 fibroblast growth factor receptor signaling pathway involved in hemopoiesis;GO:0035604 fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,yes,Predicted secreted proteins; Enzymes; Human disease related genes:Congenital malformations:Congenital malformations of the musculoskeletal system; Human disease related genes:Cancers:Cancers of the digestive system; CD markers; ENZYME proteins:Transferases; Predicted intracellular proteins; Cancer-related genes:Candidate cancer biomarkers; Kinases:Tyr protein kinases; FDA approved drug targets:Biotech drugs; Cancer-related genes:Mutated cancer genes; FDA approved drug targets:Small molecule drugs; Cancer-related genes:Mutational cancer driver genes; Human disease related genes:Congenital malformations:Other congenital malformations; Disease related genes; RAS pathway related proteins,Cell Junctions (Supported); Additional: Nucleoplasm;Vesicles,(M276)PID FGF PATHWAY,
87769,GGACT,gamma-glutamylamine cyclotransferase,GO:0042219 cellular modified amino acid catabolic process;GO:0006575 cellular modified amino acid metabolic process;GO:1901565 organonitrogen compound catabolic process,,ENZYME proteins:Lyases; Enzymes; Predicted intracellular proteins,,,
91851,CHRDL1,chordin like 1,GO:0097113 AMPA glutamate receptor clustering;GO:0097688 glutamate receptor clustering;GO:0072578 neurotransmitter-gated ion channel clustering,,Predicted secreted proteins; Human disease related genes:Nervous system diseases:Eye disease; Disease related genes,,(M181)PID BMP PATHWAY; (M5883)NABA SECRETED FACTORS; (M5885)NABA MATRISOME ASSOCIATED,
5734,PTGER4,prostaglandin E receptor 4,GO:2000419 regulation of eosinophil extravasation;GO:2000420 negative regulation of eosinophil extravasation;GO:2000417 negative regulation of eosinophil migration,,FDA approved drug targets:Small molecule drugs; G-protein coupled receptors:GPCRs excl olfactory receptors,,,(M5890)HALLMARK TNFA SIGNALING VIA NFKB; (M5932)HALLMARK INFLAMMATORY RESPONSE
830,CAPZA2,capping actin protein of muscle Z-line subunit alpha 2,GO:0051016 barbed-end actin filament capping;GO:0051693 actin filament capping;GO:0030835 negative regulation of actin filament depolymerization,,Predicted intracellular proteins,Cytosol (Approved),,
11259,FILIP1L,filamin A interacting protein 1 like,GO:0008150 biological_process,,Predicted intracellular proteins,Plasma membrane (Approved),,
1540,CYLD,CYLD lysine 63 deubiquitinase,GO:2000493 negative regulation of interleukin-18-mediated signaling pathway;GO:0097343 ripoptosome assembly;GO:1901026 ripoptosome assembly involved in necroptotic process,,Enzymes; Peptidases:Cysteine-type peptidases; Potential drug targets; Predicted intracellular proteins; Human disease related genes:Skin diseases:Skin and soft tissue diseases; ENZYME proteins:Hydrolases; Cancer-related genes:Mutational cancer driver genes; Human disease related genes:Nervous system diseases:Neurodegenerative diseases; Disease related genes,Centriolar satellite (Supported); Additional: Nucleoplasm,(M37)PID NFKAPPAB CANONICAL PATHWAY; (M128)PID TNF PATHWAY,(M5902)HALLMARK APOPTOSIS
93986,FOXP2,forkhead box P2,GO:0021757 caudate nucleus development;GO:0021758 putamen development;GO:0021756 striatum development,,Predicted intracellular proteins; Transcription factors:Helix-turn-helix domains; Human disease related genes:Other diseases:Mental and behavioural disorders; Disease related genes,Nucleoplasm (Enhanced),,
2857,GPR34,G protein-coupled receptor 34,GO:0035589 G protein-coupled purinergic nucleotide receptor signaling pathway;GO:0035590 purinergic nucleotide receptor signaling pathway;GO:0007186 G protein-coupled receptor signaling pathway,,G-protein coupled receptors:GPCRs excl olfactory receptors,Cytosol (Approved),,
92610,TIFA,TRAF interacting protein with forkhead associated domain,GO:0033209 tumor necrosis factor-mediated signaling pathway;GO:0002753 cytoplasmic pattern recognition receptor signaling pathway;GO:0002221 pattern recognition receptor signaling pathway,,Predicted intracellular proteins,Nucleoli;Nucleoplasm (Approved); Additional: Cytosol,,
11228,RASSF8,Ras association domain family member 8,GO:0007165 signal transduction;GO:0023052 signaling;GO:0007154 cell communication,,Predicted intracellular proteins; Disease related genes,Cytosol;Mitochondria (Approved),,
2742,GLRA2,glycine receptor alpha 2,GO:0071361 cellular response to ethanol;GO:0071294 cellular response to zinc ion;GO:0010043 response to zinc ion,,Transporters:Transporter channels and pores; FDA approved drug targets:Small molecule drugs; Disease related genes,Plasma membrane;Vesicles (Approved),,
494143,CHAC2,ChaC glutathione specific gamma-glutamylcyclotransferase 2,GO:0006751 glutathione catabolic process;GO:0006750 glutathione biosynthetic process;GO:0019184 nonribosomal peptide biosynthetic process,,ENZYME proteins:Lyases; Enzymes; Predicted intracellular proteins,Cytosol (Approved),,
9934,P2RY14,purinergic receptor P2Y14,GO:0035589 G protein-coupled purinergic nucleotide receptor signaling pathway;GO:0035590 purinergic nucleotide receptor signaling pathway;GO:0007186 G protein-coupled receptor signaling pathway,,G-protein coupled receptors:GPCRs excl olfactory receptors; G-protein coupled receptors:Adenosine and adenine nucleotide receptors,,,(M5913)HALLMARK INTERFERON GAMMA RESPONSE
658,BMPR1B,bone morphogenetic protein receptor type 1B,GO:0001550 ovarian cumulus expansion;GO:1902731 negative regulation of chondrocyte proliferation;GO:0048165 fused antrum stage,yes,Enzymes; Human disease related genes:Congenital malformations:Congenital malformations of the musculoskeletal system; Potential drug targets; Kinases:TKL Ser/Thr protein kinases; CD markers; ENZYME proteins:Transferases; Predicted intracellular proteins; Disease related genes,,(M181)PID BMP PATHWAY,(M5908)HALLMARK ANDROGEN RESPONSE; (M5935)HALLMARK FATTY ACID METABOLISM; (M5956)HALLMARK KRAS SIGNALING DN
3006,H1-2,"H1.2 linker histone, cluster member",GO:0030261 chromosome condensation;GO:0045910 negative regulation of DNA recombination;GO:0006334 nucleosome assembly,,Predicted intracellular proteins,Nucleoli rim;Nucleoplasm (Supported),,(M5939)HALLMARK P53 PATHWAY
23283,CSTF2T,cleavage stimulation factor subunit 2 tau variant,GO:0031124 mRNA 3'-end processing;GO:0031123 RNA 3'-end processing;GO:0006397 mRNA processing,,Predicted intracellular proteins,Nucleoplasm (Enhanced); Additional: Vesicles,,
9963,SLC23A1,solute carrier family 23 member 1,GO:0015882 L-ascorbic acid transmembrane transport;GO:0070837 dehydroascorbic acid transport;GO:0019852 L-ascorbic acid metabolic process,,Transporters:Electrochemical Potential-driven transporters,,,(M5948)HALLMARK BILE ACID METABOLISM
10209,EIF1,eukaryotic translation initiation factor 1,"GO:1905744 regulation of mRNA cis splicing, via spliceosome;GO:1905746 positive regulation of mRNA cis splicing, via spliceosome;GO:0048026 positive regulation of mRNA splicing, via spliceosome",,Predicted intracellular proteins,,,(M5890)HALLMARK TNFA SIGNALING VIA NFKB
4988,OPRM1,opioid receptor mu 1,GO:0061358 negative regulation of Wnt protein secretion;GO:0071315 cellular response to morphine;GO:0071317 cellular response to isoquinoline alkaloid,,Human disease related genes:Other diseases:Mental and behavioural disorders; Transporters; FDA approved drug targets:Small molecule drugs; G-protein coupled receptors:GPCRs excl olfactory receptors,,(M28)PID IL4 2PATHWAY,
51691,LSM8,"LSM8 homolog, U6 small nuclear RNA associated","GO:0000377 RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;GO:0000398 mRNA splicing, via spliceosome;GO:0000375 RNA splicing, via transesterification reactions",,Predicted intracellular proteins,Nucleoplasm;Vesicles (Approved),,
79161,TMEM243,transmembrane protein 243,,,Predicted intracellular proteins,,,
347240,KIF24,kinesin family member 24,GO:0007019 microtubule depolymerization;GO:1902018 negative regulation of cilium assembly;GO:0051261 protein depolymerization,,Predicted intracellular proteins,,,
23767,FLRT3,fibronectin leucine rich transmembrane protein 3,GO:0003345 proepicardium cell migration involved in pericardium morphogenesis;GO:0003344 pericardium morphogenesis;GO:0060973 cell migration involved in heart development,,Transporters:Accessory Factors Involved in Transport; Human disease related genes:Endocrine and metabolic diseases:Hypothalamus and pituitary gland diseases; Potential drug targets; Disease related genes,Plasma membrane (Supported); Additional: Cell Junctions;Cytosol,,
23452,ANGPTL2,angiopoietin like 2,GO:0007267 cell-cell signaling;GO:0023052 signaling;GO:0007154 cell communication,,Predicted secreted proteins; Predicted intracellular proteins,Golgi apparatus (Approved),(M16801)SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES; (M5193)SIG CHEMOTAXIS; (M5883)NABA SECRETED FACTORS,
5532,PPP3CB,protein phosphatase 3 catalytic subunit beta,GO:1905673 positive regulation of lysosome organization;GO:0031987 locomotion involved in locomotory behavior;GO:1905949 negative regulation of calcium ion import across plasma membrane,,Enzymes; ENZYME proteins:Hydrolases; Predicted intracellular proteins,Cytosol (Supported); Additional: Nucleoplasm,(M235)PID TCR CALCIUM PATHWAY; (M290)PID IL12 STAT4 PATHWAY; (M175)PID ERBB2 ERBB3 PATHWAY,
9358,ITGBL1,integrin subunit beta like 1,GO:0033627 cell adhesion mediated by integrin;GO:0007229 integrin-mediated signaling pathway;GO:0007160 cell-matrix adhesion,,Predicted secreted proteins; Predicted intracellular proteins; Transporters,,,(M5953)HALLMARK KRAS SIGNALING UP
388015,RTL1,retrotransposon Gag like 1,,,,Cytosol (Approved),,
2823,GPM6A,glycoprotein M6A,GO:0051491 positive regulation of filopodium assembly;GO:0051489 regulation of filopodium assembly;GO:0003407 neural retina development,,Predicted intracellular proteins,,,
23741,EID1,EP300 interacting inhibitor of differentiation 1,GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0007049 cell cycle;GO:0045892 negative regulation of DNA-templated transcription,,Predicted intracellular proteins,Nucleoplasm (Supported),,
7337,UBE3A,ubiquitin protein ligase E3A,GO:0035037 sperm entry;GO:1905528 positive regulation of Golgi lumen acidification;GO:1905526 regulation of Golgi lumen acidification,,Enzymes; Disease related genes; ENZYME proteins:Transferases; Predicted intracellular proteins; Human disease related genes:Other congenital disorders:Chromosomal abnormalities; Potential drug targets,Nucleoplasm (Approved); Additional: Cytosol,(M58)PID AR PATHWAY; (M105)PID TELOMERASE PATHWAY,
54456,MOV10L1,Mov10 like RNA helicase 1,GO:0141007 siRNA-mediated retrotransposon silencing by heterochromatin formation;GO:0141005 retrotransposon silencing by heterochromatin formation;GO:0034587 piRNA processing,,Enzymes; Disease related genes; Human disease related genes:Reproductive system diseases:Reproductive system diseases; Predicted intracellular proteins; ENZYME proteins:Hydrolases; Potential drug targets,,,
23682,RAB38,"RAB38, member RAS oncogene family",GO:0150173 positive regulation of phosphatidylcholine metabolic process;GO:2001247 positive regulation of phosphatidylcholine biosynthetic process;GO:2001245 regulation of phosphatidylcholine biosynthetic process,,Predicted intracellular proteins,Mitochondria;Nuclear bodies (Uncertain),(M236)PID DELTA NP63 PATHWAY,
64799,IQCH,IQ motif containing H,GO:0008150 biological_process,,Predicted intracellular proteins,Cytosol (Approved),,
347730,LRRTM1,leucine rich repeat transmembrane neuronal 1,GO:0099151 regulation of postsynaptic density assembly;GO:0099150 regulation of postsynaptic specialization assembly;GO:1905874 regulation of postsynaptic density organization,,Predicted intracellular proteins; Transporters:Accessory Factors Involved in Transport,Golgi apparatus (Approved),,
7150,TOP1,DNA topoisomerase I,GO:0040016 embryonic cleavage;GO:0006265 DNA topological change;GO:0032922 circadian regulation of gene expression,,Enzymes; Predicted intracellular proteins; ENZYME proteins:Isomerase; FDA approved drug targets:Biotech drugs; FDA approved drug targets:Small molecule drugs; Cancer-related genes; Disease related genes,Nucleoli fibrillar center;Nucleoplasm (Supported),(M220)PID CASPASE PATHWAY,(M5901)HALLMARK G2M CHECKPOINT; (M5945)HALLMARK HEME METABOLISM
2321,FLT1,fms related receptor tyrosine kinase 1,GO:0036323 vascular endothelial growth factor receptor-1 signaling pathway;GO:1990384 hyaloid vascular plexus regression;GO:0060033 anatomical structure regression,yes,Predicted secreted proteins; Enzymes; ENZYME proteins:Transferases; Cancer-related genes:Candidate cancer biomarkers; Kinases:Tyr protein kinases; FDA approved drug targets:Biotech drugs; FDA approved drug targets:Small molecule drugs; Disease related genes; RAS pathway related proteins,Plasma membrane (Supported); Additional: Actin filaments,(M137)PID VEGF VEGFR PATHWAY; (M226)PID VEGFR1 PATHWAY; (M33)PID GLYPICAN 1PATHWAY,
9037,SEMA5A,semaphorin 5A,GO:1990256 signal clustering;GO:0002043 blood vessel endothelial cell proliferation involved in sprouting angiogenesis;GO:0048842 positive regulation of axon extension involved in axon guidance,,Human disease related genes:Other congenital disorders:Chromosomal abnormalities; Predicted intracellular proteins,,(M5880)NABA ECM AFFILIATED; (M5885)NABA MATRISOME ASSOCIATED; (M5889)NABA MATRISOME,
257415,FAM133B,family with sequence similarity 133 member B,,,Predicted intracellular proteins,Nucleoli (Enhanced); Additional: Nucleoplasm,,
3326,HSP90AB1,heat shock protein 90 alpha family class B member 1,GO:1901389 negative regulation of transforming growth factor beta activation;GO:1902949 positive regulation of tau-protein kinase activity;GO:1905323 telomerase holoenzyme complex assembly,,Transporters:Accessory Factors Involved in Transport; Predicted intracellular proteins; Cancer-related genes:Candidate cancer biomarkers; Cancer-related genes:Mutated cancer genes; Cancer-related genes:Mutational cancer driver genes,Cytosol (Supported),(M237)PID VEGFR1 2 PATHWAY,(M5926)HALLMARK MYC TARGETS V1
3184,HNRNPD,heterogeneous nuclear ribonucleoprotein D,GO:1904585 response to putrescine;GO:1904586 cellular response to putrescine;GO:1990828 hepatocyte dedifferentiation,,Predicted intracellular proteins,Nucleoplasm (Enhanced),,(M5901)HALLMARK G2M CHECKPOINT; (M5925)HALLMARK E2F TARGETS; (M5926)HALLMARK MYC TARGETS V1
212,ALAS2,5'-aminolevulinate synthase 2,GO:0042541 hemoglobin biosynthetic process;GO:0032364 intracellular oxygen homeostasis;GO:0006782 protoporphyrinogen IX biosynthetic process,,Enzymes; Potential drug targets; Human disease related genes:Congenital disorders of metabolism:Congenital disorders of cofactor/vitamin metabolism; Human disease related genes:Cardiovascular diseases:Hematologic diseases; ENZYME proteins:Transferases; Predicted intracellular proteins; Disease related genes,,,(M5945)HALLMARK HEME METABOLISM
7010,TEK,TEK receptor tyrosine kinase,GO:0048014 Tie signaling pathway;GO:0035022 positive regulation of Rac protein signal transduction;GO:0060347 heart trabecula formation,yes,Predicted secreted proteins; Enzymes; CD markers; ENZYME proteins:Transferases; Cancer-related genes:Candidate cancer biomarkers; Kinases:Tyr protein kinases; Human disease related genes:Congenital malformations:Congenital malformations of the circulatory system; FDA approved drug targets:Small molecule drugs; Human disease related genes:Congenital malformations:Congenital malformations of eye; Disease related genes; RAS pathway related proteins,Plasma membrane (Supported); Additional: Centriolar satellite,(M92)PID ANGIOPOIETIN RECEPTOR PATHWAY; (M100)PID SHP2 PATHWAY,
246175,CNOT6L,CCR4-NOT transcription complex subunit 6 like,GO:0010606 positive regulation of cytoplasmic mRNA processing body assembly;GO:0010603 regulation of cytoplasmic mRNA processing body assembly;GO:0000289 nuclear-transcribed mRNA poly(A) tail shortening,,Enzymes; ENZYME proteins:Hydrolases; Predicted intracellular proteins,Cytosol (Supported),,
57515,SERINC1,serine incorporator 1,GO:1904217 regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;GO:1904219 positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;GO:1904222 positive regulation of serine C-palmitoyltransferase activity,,,Cytosol (Approved),,(M5935)HALLMARK FATTY ACID METABOLISM
226,ALDOA,"aldolase, fructose-bisphosphate A","GO:0030388 fructose 1,6-bisphosphate metabolic process;GO:0006000 fructose metabolic process;GO:0046716 muscle cell cellular homeostasis",,Enzymes; Human disease related genes:Congenital disorders of metabolism:Congenital disorders of carbohydrate metabolism; Potential drug targets; Predicted intracellular proteins; Cancer-related genes:Candidate cancer biomarkers; ENZYME proteins:Lyases; Disease related genes,Cytosol (Approved),(M255)PID HIF1 TFPATHWAY,(M5935)HALLMARK FATTY ACID METABOLISM; (M5941)HALLMARK UV RESPONSE UP; (M5891)HALLMARK HYPOXIA
151050,KANSL1L,KAT8 regulatory NSL complex subunit 1 like,,,Predicted intracellular proteins,Cytosol (Approved),,
8452,CUL3,cullin 3,GO:0001831 trophectodermal cellular morphogenesis;GO:0071630 nuclear protein quality control by the ubiquitin-proteasome system;GO:0140252 regulation protein catabolic process at postsynapse,,Human disease related genes:Urinary system diseases:Kidney diseases; Predicted intracellular proteins; Disease related genes,,(M90)PID WNT CANONICAL PATHWAY; (M14)PID AURORA B PATHWAY; (M166)PID ATF2 PATHWAY,(M5901)HALLMARK G2M CHECKPOINT
373509,USP50,ubiquitin specific peptidase 50,GO:0035063 nuclear speck organization;GO:0032741 positive regulation of interleukin-18 production;GO:0032661 regulation of interleukin-18 production,,Enzymes; Predicted intracellular proteins; Peptidases:Cysteine-type peptidases,,,
3151,HMGN2,high mobility group nucleosomal binding domain 2,GO:0061844 antimicrobial humoral immune response mediated by antimicrobial peptide;GO:0031640 killing of cells of another organism;GO:0141061 disruption of cell in another organism,,Predicted intracellular proteins,Nucleoplasm (Supported); Additional: Nucleoli,,(M5901)HALLMARK G2M CHECKPOINT
4907,NT5E,5'-nucleotidase ecto,GO:0046086 adenosine biosynthetic process;GO:0140928 inhibition of non-skeletal tissue mineralization;GO:0006196 AMP catabolic process,,Enzymes; Potential drug targets; CD markers; Predicted intracellular proteins; ENZYME proteins:Hydrolases; Human disease related genes:Cardiovascular diseases:Vascular diseases; Disease related genes,Plasma membrane (Supported); Additional: Cytosol;Nucleoplasm,(M255)PID HIF1 TFPATHWAY,(M5947)HALLMARK IL2 STAT5 SIGNALING; (M5930)HALLMARK EPITHELIAL MESENCHYMAL TRANSITION; (M5937)HALLMARK GLYCOLYSIS
10026,PIGK,phosphatidylinositol glycan anchor biosynthesis class K,GO:0016255 attachment of GPI anchor to protein;GO:0006506 GPI anchor biosynthetic process;GO:0006505 GPI anchor metabolic process,,Enzymes; Disease related genes; Peptidases:Cysteine-type peptidases; Predicted intracellular proteins; Human disease related genes:Congenital disorders of metabolism:Congenital disorders of lipid/glycolipid metabolism; Potential drug targets,,,
2124,EVI2B,ecotropic viral integration site 2B,GO:0045660 positive regulation of neutrophil differentiation;GO:0045658 regulation of neutrophil differentiation;GO:0030854 positive regulation of granulocyte differentiation,,CD markers,Plasma membrane (Approved),,
4869,NPM1,nucleophosmin 1,GO:0060735 regulation of eIF2 alpha phosphorylation by dsRNA;GO:1902629 regulation of mRNA stability involved in cellular response to UV;GO:0010825 positive regulation of centrosome duplication,,Predicted intracellular proteins; Cancer-related genes:Mutated cancer genes; Human disease related genes:Cancers:Cancers of haematopoietic and lymphoid tissues; Cancer-related genes:Mutational cancer driver genes; Disease related genes,Nucleoli rim (Enhanced); Additional: Nucleoplasm,(M258)PID BARD1 PATHWAY; (M14)PID AURORA B PATHWAY; (M255)PID HIF1 TFPATHWAY,(M5928)HALLMARK MYC TARGETS V2; (M5922)HALLMARK UNFOLDED PROTEIN RESPONSE; (M5926)HALLMARK MYC TARGETS V1
4747,NEFL,neurofilament light chain,GO:0045105 intermediate filament polymerization or depolymerization;GO:1903937 response to acrylamide;GO:0033693 neurofilament bundle assembly,,Human disease related genes:Nervous system diseases:Neurodegenerative diseases; Predicted intracellular proteins; Disease related genes,Intermediate filaments;Nucleoplasm (Approved); Additional: Midbody,,
55082,ARGLU1,arginine and glutamate rich 1,,,Predicted intracellular proteins,Nucleoplasm (Enhanced); Additional: Cytosol;Mitochondria,,
169966,TENT5D,terminal nucleotidyltransferase 5D,GO:0048255 mRNA stabilization;GO:0043489 RNA stabilization;GO:1902373 negative regulation of mRNA catabolic process,,Enzymes; ENZYME proteins:Transferases; Predicted intracellular proteins,,,
408263,FNDC9,fibronectin type III domain containing 9,,,,,,
64805,P2RY12,purinergic receptor P2Y12,GO:0033626 positive regulation of integrin activation by cell surface receptor linked signal transduction;GO:0035585 calcium-mediated signaling using extracellular calcium source;GO:1904141 positive regulation of microglial cell migration,,Human disease related genes:Cardiovascular diseases:Hematologic diseases; G-protein coupled receptors:GPCRs excl olfactory receptors; FDA approved drug targets:Small molecule drugs; Transporters; Disease related genes; G-protein coupled receptors:Adenosine and adenine nucleotide receptors,,,
52,ACP1,acid phosphatase 1,,,Enzymes; ENZYME proteins:Hydrolases; Predicted intracellular proteins,Nucleoplasm (Approved); Additional: Cytosol,(M273)PID EPHA2 FWD PATHWAY,(M5926)HALLMARK MYC TARGETS V1; (M5934)HALLMARK XENOBIOTIC METABOLISM
7314,UBB,ubiquitin B,GO:1902527 positive regulation of protein monoubiquitination;GO:1902525 regulation of protein monoubiquitination;GO:1902255 positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,,Predicted intracellular proteins,,,
64922,LRRC19,leucine rich repeat containing 19,GO:0032637 interleukin-8 production;GO:0048874 host-mediated regulation of intestinal microbiota composition;GO:0001816 cytokine production,,,,,
401494,HACD4,3-hydroxyacyl-CoA dehydratase 4,GO:0042761 very long-chain fatty acid biosynthetic process;GO:0030497 fatty acid elongation;GO:0000038 very long-chain fatty acid metabolic process,,ENZYME proteins:Lyases; Enzymes,,,
27429,HTRA2,HtrA serine peptidase 2,GO:0019742 pentacyclic triterpenoid metabolic process;GO:1904924 negative regulation of mitophagy in response to mitochondrial depolarization;GO:0006722 triterpenoid metabolic process,,Enzymes; Human disease related genes:Congenital disorders of metabolism:Congenital disorders of amino acid metabolism; Potential drug targets; Peptidases:Serine-type peptidases; ENZYME proteins:Hydrolases; Human disease related genes:Nervous system diseases:Neurodegenerative diseases; Disease related genes,Mitochondria (Supported),,(M5936)HALLMARK OXIDATIVE PHOSPHORYLATION; (M5945)HALLMARK HEME METABOLISM
345062,PRSS48,serine protease 48,GO:0006508 proteolysis;GO:0019538 protein metabolic process;GO:1901564 organonitrogen compound metabolic process,,Predicted secreted proteins; Enzymes; Peptidases:Serine-type peptidases,,,
3567,IL5,interleukin 5,GO:0045643 regulation of eosinophil differentiation;GO:0045645 positive regulation of eosinophil differentiation;GO:0038043 interleukin-5-mediated signaling pathway,,Cancer-related genes:Candidate cancer biomarkers; FDA approved drug targets:Biotech drugs; Predicted secreted proteins; Predicted intracellular proteins,,(M135)PID IL5 PATHWAY; (M60)PID NFAT TFPATHWAY; (M28)PID IL4 2PATHWAY,(M5956)HALLMARK KRAS SIGNALING DN
145748,LYSMD4,LysM domain containing 4,,,Predicted intracellular proteins,Cytosol (Approved); Additional: Actin filaments,,
4067,LYN,"LYN proto-oncogene, Src family tyrosine kinase",GO:0070447 positive regulation of oligodendrocyte progenitor proliferation;GO:0070667 negative regulation of mast cell proliferation;GO:2000670 positive regulation of dendritic cell apoptotic process,yes,Enzymes; Potential drug targets; ENZYME proteins:Transferases; Predicted intracellular proteins; Kinases:Tyr protein kinases; Cancer-related genes:Mutational cancer driver genes; Disease related genes,Golgi apparatus;Plasma membrane (Supported); Additional: Vesicles,(M135)PID IL5 PATHWAY; (M17200)SA B CELL RECEPTOR COMPLEXES; (M33)PID GLYPICAN 1PATHWAY,(M5916)HALLMARK APICAL SURFACE; (M5941)HALLMARK UV RESPONSE UP; (M5921)HALLMARK COMPLEMENT
10973,ASCC3,activating signal cointegrator 1 complex subunit 3,GO:1990116 ribosome-associated ubiquitin-dependent protein catabolic process;GO:0006307 DNA dealkylation involved in DNA repair;GO:0035510 DNA dealkylation,,Enzymes; ENZYME proteins:Hydrolases; Predicted intracellular proteins,Cytosol (Supported); Additional: Golgi apparatus,,
4998,ORC1,origin recognition complex subunit 1,GO:0033314 mitotic DNA replication checkpoint signaling;GO:0000076 DNA replication checkpoint signaling;GO:0006270 DNA replication initiation,,Human disease related genes:Congenital malformations:Other congenital malformations; Predicted intracellular proteins; Disease related genes,Nucleoplasm (Supported),(M40)PID E2F PATHWAY,
92421,CHMP4C,charged multivesicular body protein 4C,GO:0044878 mitotic cytokinesis checkpoint signaling;GO:0090611 ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;GO:0009838 abscission,,Predicted intracellular proteins,Cytokinetic bridge;Microtubules (Approved),,
84899,TMTC4,transmembrane O-mannosyltransferase targeting cadherins 4,GO:0032470 positive regulation of endoplasmic reticulum calcium ion concentration;GO:1905584 outer hair cell apoptotic process;GO:0035269 protein O-linked mannosylation,,Enzymes; ENZYME proteins:Transferases; Predicted intracellular proteins,Vesicles (Approved),,
29978,UBQLN2,ubiquilin 2,GO:1904021 negative regulation of G protein-coupled receptor internalization;GO:1900186 negative regulation of clathrin-dependent endocytosis;GO:1904020 regulation of G protein-coupled receptor internalization,,Human disease related genes:Nervous system diseases:Neurodegenerative diseases; Predicted intracellular proteins; Disease related genes,Cytosol (Supported); Additional: Plasma membrane,,
283652,SLC24A5,solute carrier family 24 member 5,GO:0048022 negative regulation of melanin biosynthetic process;GO:1900377 negative regulation of secondary metabolite biosynthetic process;GO:0042438 melanin biosynthetic process,,Potential drug targets; Transporters:Electrochemical Potential-driven transporters; Human disease related genes:Congenital disorders of metabolism:Congenital disorders of amino acid metabolism; Disease related genes,,,
552889,ATXN7L3B,ataxin 7 like 3B,GO:0010468 regulation of gene expression;GO:0010556 regulation of macromolecule biosynthetic process;GO:0031326 regulation of cellular biosynthetic process,,Predicted intracellular proteins; Disease related genes,Nucleoplasm (Approved),,
55743,CHFR,checkpoint with forkhead and ring finger domains,GO:0044779 meiotic spindle checkpoint signaling;GO:1902103 negative regulation of metaphase/anaphase transition of meiotic cell cycle;GO:1905133 negative regulation of meiotic chromosome separation,,Cancer-related genes:Candidate cancer biomarkers; Enzymes; ENZYME proteins:Transferases; Predicted intracellular proteins,Microtubules;Nuclear bodies (Uncertain),,(M5951)HALLMARK SPERMATOGENESIS
3187,HNRNPH1,heterogeneous nuclear ribonucleoprotein H1,"GO:0043484 regulation of RNA splicing;GO:0000377 RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;GO:0000398 mRNA splicing, via spliceosome",,Predicted intracellular proteins,Nucleoplasm (Enhanced),,
203547,VMA21,vacuolar ATPase assembly factor VMA21,GO:0070072 vacuolar proton-transporting V-type ATPase complex assembly;GO:0070070 proton-transporting V-type ATPase complex assembly;GO:0070071 proton-transporting two-sector ATPase complex assembly,,Human disease related genes:Musculoskeletal diseases:Muscular diseases; Disease related genes,,,
367,AR,androgen receptor,GO:0019102 male somatic sex determination;GO:0060520 activation of prostate induction by androgen receptor signaling pathway;GO:0018993 somatic sex determination,,Human disease related genes:Cancers:Cancers of male genital organs; Predicted intracellular proteins; Cancer-related genes:Candidate cancer biomarkers; Transcription factors:Zinc-coordinating DNA-binding domains; FDA approved drug targets:Small molecule drugs; Nuclear receptors; Cancer-related genes:Mutational cancer driver genes; Human disease related genes:Nervous system diseases:Neurodegenerative diseases; Human disease related genes:Congenital malformations:Congenital malformations of genital organs; Disease related genes,Cytosol (Supported),(M213)PID AR NONGENOMIC PATHWAY; (M285)PID HNF3A PATHWAY; (M288)PID HES HEY PATHWAY,(M5948)HALLMARK BILE ACID METABOLISM; (M5906)HALLMARK ESTROGEN RESPONSE EARLY
51714,SELENOT,selenoprotein T,GO:0001514 selenocysteine incorporation;GO:0006451 translational readthrough;GO:0060124 positive regulation of growth hormone secretion,,Enzymes; Potential drug targets; Disease related genes; ENZYME proteins:Oxidoreductases,,,
285,ANGPT2,angiopoietin 2,GO:0050928 negative regulation of positive chemotaxis;GO:0048014 Tie signaling pathway;GO:0072012 glomerulus vasculature development,,Predicted secreted proteins; Human disease related genes:Congenital malformations:Congenital malformations of skin; Cancer-related genes:Candidate cancer biomarkers; FDA approved drug targets:Biotech drugs; Disease related genes; RAS pathway related proteins,,(M92)PID ANGIOPOIETIN RECEPTOR PATHWAY; (M5883)NABA SECRETED FACTORS; (M5885)NABA MATRISOME ASSOCIATED,
8633,UNC5C,unc-5 netrin receptor C,GO:0061643 chemorepulsion of axon;GO:0033564 anterior/posterior axon guidance;GO:1990791 dorsal root ganglion development,,Predicted intracellular proteins; Disease related genes,,(M108)PID NETRIN PATHWAY,(M5919)HALLMARK HEDGEHOG SIGNALING
3858,KRT10,keratin 10,GO:0051290 protein heterotetramerization;GO:0018149 peptide cross-linking;GO:0051291 protein heterooligomerization,,Predicted secreted proteins; Human disease related genes:Congenital malformations:Congenital malformations of skin; Predicted intracellular proteins; Disease related genes,,,
4809,SNU13,small nuclear ribonucleoprotein 13,GO:0000492 box C/D snoRNP assembly;GO:0000491 small nucleolar ribonucleoprotein complex assembly;GO:0000470 maturation of LSU-rRNA,,Ribosomal proteins; Predicted intracellular proteins,,,
64320,RNF25,ring finger protein 25,GO:0085020 protein K6-linked ubiquitination;GO:0072344 rescue of stalled ribosome;GO:0032790 ribosome disassembly,,Enzymes; ENZYME proteins:Transferases; Predicted intracellular proteins,Cytosol (Approved); Additional: Actin filaments;Nucleoplasm,,
27328,PCDH11X,protocadherin 11 X-linked,GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules;GO:0098742 cell-cell adhesion via plasma-membrane adhesion molecules;GO:0098609 cell-cell adhesion,,,,,
808,CALM3,calmodulin 3,GO:1901842 negative regulation of high voltage-gated calcium channel activity;GO:0051343 positive regulation of cyclic-nucleotide phosphodiesterase activity;GO:1905913 negative regulation of calcium ion export across plasma membrane,,Predicted intracellular proteins; Human disease related genes:Cardiovascular diseases:Cardiac diseases; Disease related genes; RAS pathway related proteins,,,(M5921)HALLMARK COMPLEMENT
27039,PKD2L2,"polycystin 2 like 2, transient receptor potential cation channel",GO:0050982 detection of mechanical stimulus;GO:0009581 detection of external stimulus;GO:0009582 detection of abiotic stimulus,,Predicted intracellular proteins; Voltage-gated ion channels:Transient Receptor Potential Channels,Plasma membrane (Approved); Additional: Cytosol,,
71,ACTG1,actin gamma 1,GO:0150111 regulation of transepithelial transport;GO:1902396 protein localization to bicellular tight junction;GO:0098974 postsynaptic actin cytoskeleton organization,,Human disease related genes:Congenital malformations:Other congenital malformations; Predicted intracellular proteins; Human disease related genes:Nervous system diseases:Ear disease; Disease related genes,,(M16801)SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,(M5892)HALLMARK CHOLESTEROL HOMEOSTASIS; (M5915)HALLMARK APICAL JUNCTION
5094,PCBP2,poly(rC) binding protein 2,GO:0039694 viral RNA genome replication;GO:0075522 IRES-dependent viral translational initiation;GO:0160049 negative regulation of cGAS/STING signaling pathway,,Predicted intracellular proteins,Cytosol;Nucleoplasm (Supported),,
403314,APOBEC4,apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4,GO:0006397 mRNA processing;GO:0016071 mRNA metabolic process;GO:0006396 RNA processing,,Predicted intracellular proteins,,,
2246,FGF1,fibroblast growth factor 1,GO:0060681 branch elongation involved in ureteric bud branching;GO:0060677 ureteric bud elongation;GO:1901509 regulation of endothelial tube morphogenesis,,Predicted secreted proteins; Predicted intracellular proteins; Cancer-related genes:Candidate cancer biomarkers; FDA approved drug targets:Biotech drugs; FDA approved drug targets:Small molecule drugs; RAS pathway related proteins,Nucleoplasm (Supported),(M276)PID FGF PATHWAY; (M5883)NABA SECRETED FACTORS; (M5885)NABA MATRISOME ASSOCIATED,
23270,TSPYL4,TSPY like 4,GO:0006334 nucleosome assembly;GO:0034728 nucleosome organization;GO:0065004 protein-DNA complex assembly,,Predicted intracellular proteins,,,
415117,STX19,syntaxin 19,GO:0031629 synaptic vesicle fusion to presynaptic active zone membrane;GO:0099500 vesicle fusion to plasma membrane;GO:0048499 synaptic vesicle membrane organization,,Predicted intracellular proteins; Transporters:Accessory Factors Involved in Transport,Intermediate filaments (Approved); Additional: Cytosol,,
25957,PNISR,PNN interacting serine and arginine rich protein,,,Predicted intracellular proteins,Nuclear speckles (Supported); Additional: Cytosol;Plasma membrane,,
9068,ANGPTL1,angiopoietin like 1,GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway;GO:0007167 enzyme-linked receptor protein signaling pathway;GO:0007166 cell surface receptor signaling pathway,,Predicted secreted proteins,,(M5883)NABA SECRETED FACTORS; (M5885)NABA MATRISOME ASSOCIATED; (M5889)NABA MATRISOME,
143662,MUC15,"mucin 15, cell surface associated",,,Predicted intracellular proteins,,(M5880)NABA ECM AFFILIATED; (M5885)NABA MATRISOME ASSOCIATED; (M5889)NABA MATRISOME,
26136,TES,testin LIM domain protein,GO:0008285 negative regulation of cell population proliferation;GO:0042127 regulation of cell population proliferation;GO:0048523 negative regulation of cellular process,,Predicted intracellular proteins,Cytosol;Focal adhesion sites (Supported); Additional: Cell Junctions;Plasma membrane,,(M5891)HALLMARK HYPOXIA; (M5924)HALLMARK MTORC1 SIGNALING
128344,CIMAP3,ciliary microtubule associated protein 3,GO:0060971 embryonic heart tube left/right pattern formation;GO:0035050 embryonic heart tube development;GO:0060972 left/right pattern formation,,Predicted intracellular proteins,Vesicles (Approved),,
9122,SLC16A4,solute carrier family 16 member 4,GO:0015718 monocarboxylic acid transport;GO:0046942 carboxylic acid transport;GO:0015849 organic acid transport,,Transporters:Electrochemical Potential-driven transporters,Cytosol;Microtubules (Approved); Additional: Cytokinetic bridge,,
63926,ANKEF1,ankyrin repeat and EF-hand domain containing 1,,,Predicted intracellular proteins,Cytosol;Nucleoli fibrillar center;Plasma membrane (Approved),,
57531,HACE1,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,GO:0016601 Rac protein signal transduction;GO:0070936 protein K48-linked ubiquitination;GO:0007030 Golgi organization,,Enzymes; Disease related genes; ENZYME proteins:Transferases; Predicted intracellular proteins; Human disease related genes:Nervous system diseases:Neurodegenerative diseases; Potential drug targets,Endoplasmic reticulum (Supported); Additional: Nuclear bodies,,
28958,COA3,cytochrome c oxidase assembly factor 3,GO:0070131 positive regulation of mitochondrial translation;GO:0033617 mitochondrial cytochrome c oxidase assembly;GO:0070129 regulation of mitochondrial translation,,Human disease related genes:Congenital disorders of metabolism:Mitochondrial diseases; Disease related genes,Mitochondria (Enhanced),,
10846,PDE10A,phosphodiesterase 10A,GO:0046069 cGMP catabolic process;GO:0010754 negative regulation of cGMP-mediated signaling;GO:0006198 cAMP catabolic process,,Human disease related genes:Nervous system diseases:Other nervous and sensory system diseases; Enzymes; Predicted intracellular proteins; ENZYME proteins:Hydrolases; FDA approved drug targets:Small molecule drugs; Human disease related genes:Nervous system diseases:Neurodegenerative diseases; Disease related genes,,,
